Staidson Therapeutic Pipelines

ProgramIndicationsDiscoveryPreclinical/IND-EnablingPhase I (2021)Phase IIPhase III
STSA-1005COVID-19/Autoimmune
SB-1901Immuno-Oncology
SB-1802Autoimmune Diseases
SB-1902Immuno-Oncology
SB-2001Immuno-Oncology
SB-2002Immuno-Oncology